Internal Medicine Grand Rounds-16462-------11/19/2013, Stanton Gerber Hall
'Anti-Mullerian Hormone: Sporadic Anovulation and Variation Across the Menstrual Cycle', Kerri Kissell, M.D.
Dr. Krissell reports there is NOT any relevant financial interest/arrangement of affiliation with one or more organizations which could be perceived as a real or apparent
COI in the context of this presentation. This Continuing Medical Education activity has not received support from any commercial source.
How well did this activity meet the stated learning objectives?ExcellentAbove AverageAverageBelow AveragePoor
Describe how AMH is currently used in clinical practice          
Recognize AMH as a marker for anovulatory disorders          
Describe the biological rational for variation of AMH across the menstrual cycle          
Please rate this presentation:ExcellentAbove AverageAverageBelow AveragePoor
Balanced, Objective, and Evidence Based          
Appropriate for intended audience          
Rate your level of knowledge BEFORE this educational activity          
Rate your level of knowledge AFTER this educational activity          
How well did this activity address a need you have in your practice          
Free of commercial bias    
Based on what you heard today:
Which physician attributes (core competencies) did the speaker incorporate into their presentation? Please choose all which apply:
Patient Care
Practice-Based Learning & Improvement
Medical Knowledge
System-Based Practice
Interpersonal & Communication Skills
Which of the following is false in regards to AMH?
A). AMH is a marker of ovarian reserve-- B). Both elevated serum levels and low serum levels of AMH are poor prognostic indicators
C). Serum AMH levels do not vary across the menstrual cycle-- D). AMH is responsible for regression of Mullerian ducts in males-- E). AMH is elevated in women with Polycystic Ovarian Syn
Correct answer is: C          
What new information/strategy do you plan to implement into your clinical practice?
What challenges or barriers might prevent you from implementing this new information/strategy?
What topics do you feel need to be addressed in future CME activities?
If you have questions, concerns, or comments about this activity, please contact: Barbara Sucher, M.B.A., Associate Dean for CME or 423.439.8081. Form Revised 4-2013